1. Stocks
  2. Akari Therapeutics Plc - ADR
  3. Swot
swot-logo

Akari Therapeutics Plc - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Akari Therapeutics Plc - ADR has 8 Strengths, 15 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Month

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Stock gained more than 20% in one month

Stock with Low PE (PE < = 10)

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

Negative Breakdown Third Support (LTP < S3)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Highest fall from 52 Week High

Biggest Price Losers from Open

Top Losers

Negative Breakdown First Support (LTP < S1)

Negative Breakdown Second Support (LTP < S2)

Negative Breakdown third support (LTP < S3)

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak Momentum: Price below Short, Medium and Long Term Averages

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Stocks rising sharply on very low month volumes